Drug intelligence / Profile preview

Alamin SN Injection

Development stage
Unknown
Lead developer
Albert David
Modality
Small Molecules
Administration
Intravenous
01

Overview

Alamin SN Injection is a sterile, non-pyrogenic, nutritional amino acid infusion developed and manufactured by Albert David. It is a 10% amino acid solution designed for parenteral nutrition to provide a balanced profile of essential and non-essential amino acids to patients who cannot receive adequate oral or enteral nutrition. The formulation typically includes 15 amino acids: L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Phenylalanine, L-Threonine, L-Tryptophan, L-Valine, L-Arginine, L-Histidine, Glycine, L-Alanine, L-Proline, L-Serine, and L-Tyrosine. It is indicated for the prevention and treatment of nitrogen loss or for maintaining negative nitrogen balance in conditions such as post-operative recovery, severe trauma, or gastrointestinal disorders where the digestive tract is non-functional or inaccessible.

Brand names
Alamin SN Injection
Other names
Alamin SN

Beyond the preview

Go deeper on Alamin SN Injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alamin SN Injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call